Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MtiSS: Mitochondrial Function in Septic Patients
NCT03748537Completed
- Sponsor
- Chiang Mai University
- Start
- Jan 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of hydrocortisone in septic shock (2 arms), sponsored by Chiang Mai University. Primary endpoints: Level of mitochondrial respiration at 7 days, Level of mitochondrial stress at 7 days and 1 more. Started Jan 2017; status: completed.
02
Drugs
hydrocortisone
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT03748537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03748537.